From there, we build a customized plan that may also include complementary therapies to support whole-body healing
A provider should review symptoms, medications, labs, safety risks, and treatment goals before peptide therapy is considered
Nothing on this page constitutes dosing advice for human or veterinary administration, and the linked guide is written for research protocol design only
For most adults using a half-inch needle at the abdomen, 90 degrees is standard
This stronger stimulation is what drives its superior efficacy for visceral fat reduction
not primarily appetite-driven (OUP Academic) Expected weight loss (this is where many people get misled) In major obesity trials: Semaglutide 2.4 mg weekly: ~14.9% mean weight loss at 68 weeks (STEP-1) (PubMed) Tirzepatide: ~15.0% to ~20.9% mean weight loss at 72 weeks , dose-dependent (SURMOUNT-1) (PubMed) AOD-9604s best-known human signal is kilograms, not double-digit percentages , and later studies did not sustain a strong obesity-drug profile